Literature DB >> 21609911

Effect of treatment with betahistine dihydrochloride on the postural stability in patients with different duration of benign paroxysmal positional vertigo.

Katerina Stambolieva1, Georgi Angov.   

Abstract

The effect of betahistine dihydrochloride on the postural stability after repositioning Epley's maneuver (EM) in patients with BPPV was evaluated by static posturography in open and closed eyes conditions. Ninety patients were divided into four groups by duration (less and above 60 days of BPPV) and by treatment (with and without treatment with betahistine). The investigation was made one hour after the positive Dix-Hallpike test, 10 and 20 days after the treatment with EM. "Sway velocity" (SV) was calculated to evaluate postural stability. The results show dependence between efficacy of treatment with betahistine applied after EM and duration of BPPV. Betahistine normalized postural stability of patients with duration of BPPV less than 60 days after 10 days of treatment and had less effect on patients with duration of BPPV above 60 days. We assume that after removing the otoconia betahistine plays an important role for improving blood flow in the inner ear. The short presence of otoconia didn't damage sensory receptor, and restoring the normal function of motion-sensitive hairs cells and stabilizing the posture was observed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21609911

Source DB:  PubMed          Journal:  Int Tinnitus J        ISSN: 0946-5448


  5 in total

1.  The evaluation of tinnitus and auditory brainstem response in benign paroxysmal positional vertigo accompanied by tinnitus.

Authors:  Ece Kocabaş; Ahmet Kutluhan; Banu Müjdeci
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-10       Impact factor: 2.503

2.  High stimulus rate brainstem auditory evoked potential in benign paroxysmal positional vertigo.

Authors:  Juan-Wen He; Qiang Gong; Xue-Feng Wang; Zheng Xiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-09       Impact factor: 2.503

3.  Effects and safety profile of betahistine in patients in the Russian contingent of OSVaLD, an open-label observational study in vestibular vertigo.

Authors:  Svetlana Vyacheslavovna Morozova; Natalia Stepanovna Alekseeva; Sergey Vasilyevich Lilenko; Eduard Ivanovich Matsnev; Oleg Anatol'evich Melnikov
Journal:  Int J Gen Med       Date:  2015-01-22

4.  Efficacy of methylprednisolone for treatment of persistent vertigo.

Authors:  Guo-Rong Ding; Jian-Ming Ni; Shan-Jing Zhang; Yan-Zhong Xie; Jun-Fei Feng
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

5.  Betahistine add-on therapy for treatment of subjects with posterior benign paroxysmal positional vertigo: a randomized controlled trial.

Authors:  Ibrahim Sayin; Recep Haydar Koç; Dastan Temirbekov; Selcuk Gunes; Musa Cirak; Zahide Mine Yazici
Journal:  Braz J Otorhinolaryngol       Date:  2020-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.